Deputy Director of The State Expert Center of the Ministry of Health of Ukraine on Clinical Trials (Ukraine) PhD, 60 published works.
One of the key policy makers of clinical trial regulatory environment in Ukraine.
Professional activities: expert evaluation of preclinical and clinical studies, development of clinical trial regulations at the national level.

Dr. Martine Dehlinger-Kremer is President of EUCROF, the European CRO Federation; Vice President, Global Medical and Regulatory Affairs at SynteractHCR , a CRO with headquarters in California and 11 other offices internationally. She is also a Board member of EFGCP (European Forum for GCP). Dr. Dehlinger-Kremer has 30 years of experience in the clinical research industry,

including more than 27 years of progressively higher levels of Regulatory and Medical Affairs leadership responsibility.
Dr. Dehlinger-Kremer has contributed to the global development of numerous products, including orphan drugs and biosimilars. She has participated in more than 100 New Drug Applications (NDAs) and Marketing Authorization Applications (MAAs) globally and in numerous clinical studies across all phases.
Dr. Dehlinger-Kremer has served as Chair of the Paediatric Working Group of EUCROF since 2008 and has influenced the standards, protocols and number of trials conducted for drugs being administered to children. Dr. Dehlinger-Kremer is chair of the EFGCP Children Medicines Working Party. Dr. Dehlinger-Kremer is also Member of Working Parties of Enpr-EMA, the European Network of Paediatric Research at the European Medicines Agency.
Dr Dehlinger-Kremer was Named One of PharmaVOICE 100’s Most Inspiring People in Life Sciences (Industry leader recognized for impact, experience and advocacy in clinical research) in August 2015.

Medical and technology innovator and clinical trial professional. Currently joined with leading biopharmaceutical company Roche and leads Regional Study Manager position for Central and Eastern Europe. Solely responsible for several international clinical trials from Western to Eastern Europe in several therapeutic areas: inflammatory, immunology, arthritis, oncology (many indications), neurology (adult and paediatric population), cardiology (medical device) dermatology. As medical technology passionate leads some innovation ideas and project in Europe at IDEA Network Group at Roche. As Ambassador role of this IDEA Roche group, responsible for new technological innovation implementation around the patient-centricity approach and innovation thinker and promoter of the great idea about process, procedures and medication development optimization approach at clinical operational level.

Jeffrey T. Apter, M.D., President of Global Clinical Trials LLC, President and Medical Director of Princeton Medical Institute and Global Medical Institutes LLC, directs clinical trials in the areas of CNS and especially Alzheimer’s disease. Dr. Apter has been the Principal Investigator for over 100 trials in Depression, Anxiety disorders, Bipolar Disorder, Schizophrenia and Alzheimer’s Disease.
Dr. Apter, a nationally renowned psychopharmacologist, is a senior attending physician at the University Medical Center at Princeton and a research collaborator in the Department of Psychology at Princeton University. Dr Apter has been actively involved in the Alzheimer Association as is a member of the NJ Alzheimer Association Scientific Advisory Board.

Economist specialised in European Project Management, Project Manager of the EU-funded Projects involving a number of partners from Europe, North America and North Africa.
Acting as non-profit Sponsor, he is strongly involved in the enhancement of paediatric research. He is member of the Paediatric Working Group of the EUCROF and coordinator of the TEDDY - European Network of Excellence for Paediatric Clinical Research, an independent Research Network (category 1 network member of Enpr-EMA, the European Network of Paediatric Research at the European Medicines Agency), composed by 48 partners from 19 EU and non-EU countries aimed at facilitating the performance of good quality paediatric studies and research.
Donato Bonifazi is involved in the PedCRIN (Paediatric Clinical Research Infrastructure Network - GA 731046, INFRADEV-3-2016) project as WP3 Leader, dedicated to the development of tools to facilitate paediatric clinical trials. The PedCRIN Project is very important, as it represents the first step in the design of the new European Paediatric Research Infrastructure.

Dagmar Chase graduated in Computer Science with a secondary focus on Theoretical Medicine from the Technical University in Munich and has a PhD in Human Biology from the Medical Faculty of the University in Ulm, Germany. Dagmar Chase co-founded the company GMI, a full service CRO, in 1983. Besides developing GMI into one of the largest CROs in Germany, she concentrated on Quality Management as well as the development of training programs for the pharmaceutical industry. Dagmar Chase was instrumental in the merger of GMI with the US-based CRO Kendle International Inc in 1997 (now INC Research), holding the position of vice president until 2004.
In 2004, Dagmar Chase started up Clinrex, a consultancy firm for clinical research. Besides providing training, she focuses on Quality Management of clinical trials with a special focus on GCP gap analyses, inspection readiness, investigator initiated trials and working with CROs. She also manages the interface to DSMBs/DMCs.
Dagmar Chase is a co-founder of the German CRO association BVMA, which was established in 1991. She is the president of the BVMA since 2001.
In addition, she is a co-founder of EUCROF, the EU CRO Federation, which was established in 2005 and for which she held the position of vice-president over a period of 10 years.

Networker through Customers, Colleagues, Professional Associations and Conferences.

Jerome is Vice President of Clinical Site Operations at StudyKIK and regularly presents workshops for a non-profit, SCORE in Orange County, CA. Previous to the clinical trial industry, Jerome was a social media consultant for businesses across the US and he has published multiple e-books and video training series' on the topic of social media marketing.
His professional passion is the use of Social Media as a new highly innovative and disruptive technology to clinical trials; the latest techniques for patient recruitment, retention and advocacy across the new and old platforms including: Snapchat, Instagram and Facebook.